Compare · 3 funds side by side · dividends reinvested

FMED, QLTY and CIBR

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$17,492CIBR · best of the three

02 / 04

FMED, QLTY and CIBR, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

GMO US Quality ETFUS Stock Styles · Factor0.50%0.65%+12.8%+17.5%[…][…]−11.7%13.1%$5.6B1.7

First Trust Nasdaq Cybersecurity ETFThematic · Cyber & cloud0.58%0.43%+27.7%+21.3%+27.4%+11.8%−20.6%31.1%$16.9B1.9

Fidelity Disruptive Medicine ETFThematic · Disruptive tech0.50%0.00%+14.6%+19.1%+15.4%[…]−18.3%24.6%$53M2.0

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 5, 2026 · returns include dividends · since: FMED 2020 · QLTY 2023 · CIBR 2015

Head to Head

Swap sides Versus in desk

Head to Head

GMO US Quality ETF · $5.6B[…]

QLTY

CIBR

First Trust Nasdaq Cybersecurity ETF · $16.9B$17,492

$10,000 five years ago, dividends reinvested · they hold 8.8% in common

QLTYMeasureCIBR

+12.8%Year to dateJan 1 → Nov 5+27.7%

+17.5%1 yearTotal return+21.3%

[…]3 years · per year$10,000 became […] · $20,670+27.4%

[…]5 years · per year$10,000 became […] · $17,492+11.8%

0.50%Expense ratio$50 · $58 a year on $10k · lower is better0.58%

0.65%Trailing 12-mo yield$65 · $43 a year on $10k0.43%

−11.7%Worst dropSmaller is better−20.6%

13.1%VolatilityLower is calmer31.1%

QLTYCIBR Winner of the row, in its colourEach row: the bigger of the two fills its side

4–2QLTY wins

End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

QLTY vs CIBR: Top 5 Holdings

Today

QLTY

24.9%in top 5

CIBR

in top 537.2%

QLTYStockCIBR

not top 5CRWD8.6%

8.2%MSFTnot top 5

not top 5CSCO7.7%

not top 5PANW7.5%

not top 5AVGO7.2%

not top 5FTNT6.2%

4.4%JNJnot top 5

4.3%TMOnot top 5

4.2%GOOGLnot top 5

4.0%METAnot top 5

Held in common8.8%

End-of-day Nov 5, 2026 · share of each fund

QLTY vs CIBR Returns, Every Period

GMOQLTY

+17.5%

past year

CIBRFirst Trust

+21.3%

past year

QLTYCIBRFaded: behind in that period

0–2CIBR wins

End-of-day Nov 5, 2026 · dividends in · faded = behind in that period

Stocks vs Thematic: QLTY vs CIBR

YTD

GMOQLTY

+12.8%

CIBRFirst Trust

+27.7%

+12.8%Year to date+27.7%

−11.7%Worst drop · 1Y−20.6%

13.1%Volatility · 1Y31.1%

0.7%Yield0.4%

$5.6BAssets$16.9B

3–1QLTY wins

End-of-day Nov 5, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: FMED, QLTY, CIBR

Today

0.50%lowest, FMED

FundExpense ratioFee$10k

FMED0.50%$50

QLTY0.50%$50

CIBR0.58%$58

End-of-day Nov 5, 2026 · fee on $10,000 a year

Yields: FMED, QLTY, CIBR

0.65%highest, QLTY

FundTrailing yieldYield$10k

QLTY0.65%$65

CIBR0.43%$43

FMED0.00%$0

End-of-day Nov 5, 2026 · trailing 12-month yield

Income After Fees on $10,000

$15most kept, QLTY

QLTY$65 − $50 = $15

CIBR$43 − $58 = −$15

FMED$0 − $50 = −$50

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee

Overlap: FMED, QLTY, CIBR

Today

8.8%most shared, QLTY and CIBR

FMEDQLTYCIBR

FMED—7.7%0.0%

QLTY7.7%—8.8%

CIBR0.0%8.8%—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+21.3%CIBR, at 31.1% volatility

QLTYWorst drop−11.7%13.1% vol

FMEDWorst drop−18.3%24.6% vol

CIBRWorst drop−20.6%31.1% vol

End-of-day Nov 5, 2026 · up and left is better

Paid More vs Made More

YTD

QLTYCIBR

+12.8%Year to date+27.7%

0.7%Yield0.4%

+17.5%Past year+21.3%

0.50%Fee0.58%

2–2level

End-of-day Nov 5, 2026

Popular Pairs Near These Three

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.6BAssets$46.8B

2–0JEPQ wins

End-of-day Nov 5, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.4%

SPYSPDR

+8.3%

+8.4%Year to date+8.3%

1.1%Yield1.0%

$182BAssets$819B

2–0SPYM wins

End-of-day Nov 5, 2026